CTOs on the Move

Humacyte

www.humacyte.com

 
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.humacyte.com
  • 2525 E NC Highway 54
    Durham, NC USA 27713
  • Phone: 919.313.9633

Executives

Name Title Contact Details

Funding

Humacyte raised $150M on 10/20/2015
Humacyte raised $18M on 10/02/2017
Humacyte raised $150M on 06/11/2018
Humacyte raised $50M on 04/14/2021
Humacyte raised $38M on 04/14/2021

Similar Companies

Affinity Benefit Services

Affinity Benefit Services is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alliance Imaging

Alliance Imaging is a locally owned and managed medical imaging facility that provides advanced imaging services in a safe and comfortable clinic setting. They offer a lower cost of care option and are conveniently located on the south side of St. Cloud.

Pet First Health Care

Pet First Health Care is a Jeffersonville, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Combe Incorporated

Like everything from Combe, this family of Brimms products is famous for quality. These products reflect the exceptionally high standards Combe holds to provide customers with complete satisfaction.

ProPhase Labs

ProPhase Labs (NASDAQ: PRPH) is a diversified medical science and technology company. The Company`s laboratory testing subsidiary, ProPhase Diagnostics, offers SARS-CoV-2 (COVID-19) and COVID-19 viral mutation PCR tests through both saliva and nasal swab methods at its CLIA certified laboratories. Critical to Covid testing, results are typically provided in under 24 hours. ProPhase Diagnostics also provides Respiratory Pathogen Panel (RPP) Molecular tests including Influenza A and B and others. ProPhase Labs researches, develops, manufactures, distributes, markets and sells OTC consumer healthcare products and dietary supplements, including dietary supplements under the TK Supplements® brand. The Company actively pursues strategic investments and acquisition opportunities for other companies, technologies and products.